Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study

Background: The time schedules for response evaluation of epidermal growth factor receptor-tyrosine kinase Inhibitor (EGFR-TKI) in non-small cell lung cancer (NSCLC) patients are still ill-defined. Methods: Stage IIIB/IV patients with histologically proven NSCLC were enrolled in this study if the t...

Full description

Bibliographic Details
Main Authors: John WC Chang, Ming-Mo Hou, Jia-Juan Hsieh, Yun-Chung Cheung, Hung-Ming Wang, Jen-Shi Chen, Cheng-Hsu Wang, Chih-Hung Chen, Kun-Yun Yeh, Li-Ying Ou, Chia-Hsun Hsieh, Hong-Dar Isaac Wu, Ying-Tsong Chen, Il-Chi Chang, Shiu-Feng Huang
Format: Article
Language:English
Published: Elsevier 2015-06-01
Series:Biomedical Journal
Subjects:
Online Access:http://www.biomedj.org/article.asp?issn=2319-4170;year=2015;volume=38;issue=3;spage=221;epage=228;aulast=Chang

Similar Items